
Allowing the federal government to negotiate with pharmaceutical companies for Medicare drugs would save $20 billion a year, says a new report from the Institute for America's Future.
Legislation to allow such negotiations has already passed the House, but was blocked in the Senate on Wednesday.
Senate urged to alter Part D [Herald News]
Senate Bars Medicare Talks for Lower Drug Prices [New York Times]